Association of immune response with efficacy and safety outcomes in adults with phenylketonuria administered pegvaliase in phase 3 clinical trials

EBioMedicine - Tập 37 - Trang 366-373 - 2018
Soumi Gupta1, Kelly Lau1, Cary O. Harding2, Gillian Shepherd3, Ryan Boyer1, John P. Atkinson4, Vijaya Knight5, Joy Olbertz1, Kevin Larimore1, Zhonghu Gu1, Mingjin Li1, Orli Rosen1, Stephen J. Zoog1, Haoling H. Weng1, Becky Schweighardt1
1BioMarin Pharmaceutical Inc., 105 Digital Dr, Novato, CA 94949, United States
2Oregon Health & Science University, 3181 SW Sam Jackson Park Rd, Portland, OR 97239, United States
3Weill Medical College of Cornell University, 47 East 91st St, New York, NY 10128, United States
4Washington University School of Medicine, Campus Box 8045, 660 S. Euclid Ave, St. Louis, MO 63110, United States
5National Jewish Health Advanced Diagnostic Laboratories, 1400 Jackson St, Denver, CO 80206, United States

Tài liệu tham khảo

Thông tin
Thông tin xuất bản

EBioMedicine

Tập 37

366-373

Thông tin tác giả